Rinaldi, E. The First Homoplastic Limb Transplant According to the Legend of Saint Cosmas and Saint Damian. Italian Journal of Orthopedics and Traumatology. 1987;13(3):393–406.Google Scholar

Dutkowski, P, De Rougemont, O, Clavien, PA. Alexis Carrel: Genius, Innovator and Ideologist. American Journal of Transplantation. 2008;8(10):1998–2003.Google Scholar

Billingham, RE, Brent, L, Medawar, PB. Actively Acquired Tolerance of Foreign Cells. Nature. 1953 Oct 3;172(4379):603–6. PubMed PMID: 13099277.Google Scholar

Snell, GD. The Genetics of Transplantation. Ann N Y Acad Sci. 1957 Dec 16;69(4):555–60. PubMed PMID: 13488312.Google Scholar

Gorer, PA, Boyse, EA. Pathological Changes in F1 Hybrid Mice Following Transplantation of Spleen Cells from Donors of the Parental Strains. Immunology. 1959 Apr;2(2):182–93. PubMed PMID: 13653737.Google Scholar

Dausset, J, Rapaport, FT, Colombani, J, Feingold, N. A Leucocyte Group and Its Relationship to Tissue Histocompatibility in Man. Transplantation. 1965 Nov;3(6):701–5. PubMed PMID: 5324831.Google Scholar

Doherty, PC, Zinkernagel, RM. A Biological Role for the Major Histocompatibility Antigens. Lancet. 1975 Jun 28;1(7922):1406–9. PubMed PMID: 49564.Google Scholar

Petersdorf, E. The HLA Complex in Biology and Medicine: A Resource Book. Bone Marrow Transplant. 2011 04//print;46(4):625.Google Scholar

Marsh, SGE, Albert, ED, Bodmer, WF, Bontrop, RE, Dupont, B, Erlich, HA, et al. Nomenclature for Factors of the HLA System, 2010. Tissue Antigens. 2010;75(4):291–455.CrossRefGoogle ScholarPubMed

Hennecke, J, Wiley, DC. T Cell Receptor-MHC Interactions up Close. Cell. 2001 Jan 12;104(1):1–4. PubMed PMID: 11163234.CrossRefGoogle ScholarPubMed

Burgdorf, S, Kautz, A, Bohnert, V, Knolle, PA, Kurts, C. Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation. Science. 2007 Apr 27;316(5824):612–6. PubMed PMID: 17463291.Google Scholar

Cresswell, P, Ackerman, AL, Giodini, A, Peaper, DR, Wearsch, PA. Mechanisms of MHC Class I-restricted Antigen Processing and Cross-presentation. Immunol Rev. 2005 Oct;207:145–57. PubMed PMID: 16181333. Epub 2005/09/27. English.Google ScholarPubMed

Goulmy, E. Human Minor Histocompatibility Antigens. Current Opinion in Immunology. 1996 Feb;8(1):75–81. PubMed PMID: 8729449.CrossRefGoogle ScholarPubMed

Goulmy, E. Minor Histocompatibility Antigens: From Transplantation Problems to Therapy of Cancer. Human Immunology. 2006 Jun;67(6):433–8. PubMed PMID: 16728266.Google Scholar

Nielsen, HS. Secondary Recurrent Miscarriage and H-Y Immunity. Human Reproduction Update. 2011 July 1, 2011;17(4):558–74.Google Scholar

Dierselhuis, M, Goulmy, E. The Relevance of Minor Histocompatibility Antigens in Solid Organ Transplantation. Curr Opin Organ Transplant. 2009 Aug;14(4):419–25. PubMed PMID: 19444105. Epub 2009/05/16. English.Google Scholar

Mutis, T, Gillespie, G, Schrama, E, Falkenburg, JH, Moss, P, Goulmy, E. Tetrameric HLA Class I-minor Histocompatibility Antigen Peptide Complexes Demonstrate Minor Histocompatibility Antigen-specific Cytotoxic T Lymphocytes in Patients with Graft-versus-Host Disease. Nat Med. 1999 Jul;5(7):839–42. PubMed PMID: 10395333. Epub 1999/07/08. English.Google Scholar

Spierings, E, Vermeulen, CJ, Vogt, MH, Doerner, LEE, Falkenburg, JHF, Mutis, T, et al. Identification of HLA Class II-restricted H-Y-specific T-helper Epitope Evoking CD4+ T-helper Cells in H-Y-mismatched Transplantation. Lancet. 2003 Aug 23;362(9384):610–5. PubMed PMID: 12944060.Google Scholar

van Els, CA, Zantvoort, E, Jacobs, N, Bakker, A, van Rood, JJ, Goulmy, E. Graft-versus-Host Disease Associated T Helper Cell Responses Specific for Minor Histocompatibility Antigens Are Mainly Restricted by HLA-DR Molecules. Bone Marrow Transplantation. 1990 Jun;5(6):365–72. PubMed PMID: 2142441.Google Scholar

Anderson, MS, Su, MA. Aire and T Cell Development. Current Opinion in Immunology. 2011;23(2):198–206. PubMed PMID: 21163636. Pubmed Central PMCID: NIHMS259332 PMC3073725.Google Scholar

Boros, P, Bromberg, JS. De Novo Autoimmunity after Organ Transplantation: Targets and Possible Pathways. Human Immunology. 2008;69(7):383–8. PubMed PMID: 18638653.CrossRefGoogle ScholarPubMed

Veillette, GR, Sahara, H, Meltzer, AJ, Weiss, MJ, Iwamoto, Y, Kim, KM, et al. Autoimmune Sensitization to Cardiac Myosin Leads to Acute Rejection of Cardiac Allografts in Miniature Swine. Transplantation. 2011;91(11):1187–91. PubMed PMID: 21512437. Pubmed Central PMCID: NIHMS339140 PMC3232060.CrossRefGoogle ScholarPubMed

Takase, H, Yu, CR, Mahdi, RM, Douek, DC, Dirusso, GB, Midgley, FM, et al. Thymic Expression of Peripheral Tissue Antigens in Humans: A Remarkable Variability among Individuals. International Immunology. 2005;17(8):1131–40. PubMed PMID: 16030131. PubMed Central PMCID: NIHMS44922 PMC2366090.CrossRefGoogle ScholarPubMed

Suthanthiran, M, Strom, TB. Renal Transplantation. New England Journal of Medicine. 1994 Aug 11;331(6):365–76. PubMed PMID: 7832839.Google Scholar

Krensky, AM. The HLA System, Antigen Processing and Presentation. Kidney International – Supplement. 1997 Mar;58:S2–7. PubMed PMID: 9067934.Google Scholar

Jiang, S, Herrera, O, Lechler, RI. New Spectrum of Allorecognition Pathways: Implications for Graft Rejection and Transplantation Tolerance. Current Opinion in Immunology. 2004 Oct;16(5):550–7. PubMed PMID: 15341998.Google Scholar

Brown, K, Sacks, SH, Wong, W. Coexpression of Donor Peptide/Recipient MHC Complex and Intact Donor MHC: Evidence for a Link between the Direct and Indirect Pathways. Am J Transplant. 2011 Apr;11(4):826–31. PubMed PMID: 21401861. Epub 2011/03/16. English.CrossRefGoogle ScholarPubMed

Hsu, KC, Chida, S, Geraghty, DE, Dupont, B. The Killer Cell Immunoglobulin-like Receptor (KIR) Genomic Region: Gene-order, Haplotypes and Allelic Polymorphism. Immunol Rev. 2002 Dec;190:40–52. PubMed PMID: 12493005. Epub 2002/12/21. English.CrossRefGoogle ScholarPubMed

Beksac, M, Dalva, K. Role of Killer Immunoglobulin-like Receptor and Ligand Matching in Donor Selection. Bone Marrow Research. 2012;2012:271695. PubMed PMID: 23193479. PubMed Central PMCID: PMC3502759. Epub 2012/11/30. English.Google Scholar

Nowak, I, Magott-Procelewska, M, Kowal, A, Miazga, M, Wagner, M, Niepieklo-Miniewska, W, et al. Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation. PLoS One. 2012;7(9):e44718. PubMed PMID: 23028591. PubMed Central PMCID: PMC3441441. Epub 2012/10/03. English.Google Scholar

Zhang, Y, Ruiz, P. Solid Organ Transplant-associated Acute Graft-versus-Host Disease. Arch Pathol Lab Med. 2010 Aug;134(8):1220–4. PubMed PMID: 20670147. Epub 2010/07/31. English.Google Scholar

Burdick, JF, Vogelsang, GB, Smith, WJ, Farmer, ER, Bias, WB, Kaufmann, SH, et al. Severe Graft-versus-Host Disease in a Liver-transplant Recipient. New England Journal of Medicine. 1988 Mar 17;318(11):689–91. PubMed PMID: 3278235.Google Scholar

Chan, EY, Larson, AM, Gernsheimer, TB, Kowdley, KV, Carithers, RL Jr., Reyes, JD, et al. Recipient and Donor Factors Influence the Incidence of Graft-vs.-Host Disease in Liver Transplant Patients. Liver Transplantation. 2007 Apr;13(4):516–22. PubMed PMID: 17394149.Google Scholar

Ghali, MP, Talwalkar, JA, Moore, SB, Hogan, WJ, Menon, KVN, Rosen, CB. Acute Graft-versus-Host Disease after Liver Transplantation. Transplantation. 2007 Feb 15;83(3):365–6. PubMed PMID: 17297417.Google Scholar

Olszewski, WL. Donor DNA Is Present in Recipient Tissues after Grafting also in Graft-versus-Host Disease-free Individuals. Transplantation. 2007 Jan 15;83(1):107–8. PubMed PMID: 17220809.Google Scholar

Perri, R, Assi, M, Talwalkar, J, Heimbach, J, Hogan, W, Moore, SB, et al. Graft vs. Host Disease after Liver Transplantation: A New Approach Is Needed. Liver Transplantation. 2007 Aug;13(8):1092–9. PubMed PMID: 17663410.Google Scholar

Assi, MA, Pulido, JS, Peters, SG, McCannel, CA, Razonable, RR. Graft-vs.-Host Disease in Lung and Other Solid Organ Transplant Recipients. Clinical Transplantation. 2007 Jan–Feb;21(1):1–6. PubMed PMID: 17302584.CrossRefGoogle ScholarPubMed

Wu, G, Selvaggi, G, Nishida, S, Moon, J, Island, E, Ruiz, P, et al. Graft-versus-Host Disease after Intestinal and Multivisceral Transplantation. Transplantation. 2011 Jan 27;91(2):219–24. PubMed PMID: 21076376. Epub 2010/11/16. English.Google Scholar

Klingebiel, T, Schlegel, PG. GVHD: Overview on Pathophysiology, Incidence, Clinical and Biological Features. Bone Marrow Transplantation. 1998 Apr;21 Suppl 2:S45–9. PubMed PMID: 9630325.Google Scholar

Triulzi, DJ, Nalesnik, MA. Microchimerism, GVHD, and Tolerance in Solid Organ Transplantation. Transfusion. 2001 Mar;41(3):419–26. PubMed PMID: 11274601.Google Scholar

Flesland, O, Pfeffer, PF, Solheim, BG, Mellbye, OJ. Donor Lymphocytes Transferred with the Graft to Kidney Recipients. Potential for Establishing Microchimerism. Transfusion & Apheresis Science. 2003;28(2):125–8. PubMed PMID: 12679115.Google Scholar

Wiebe, BM, Mortensen, SA, Petterson, G, Svendsen, UG, Andersen, CB. Macrophage and Lymphocyte Chimerism in Bronchoalveolar Lavage Cells from Human Lung Allograft Recipients. APMIS. 2001;109(6):435–40. PubMed PMID: 11506475.Google Scholar

Petersdorf, EW, Malkki, M. Genetics of Risk Factors for Graft-versus-Host Disease. Seminars in Hematology. 2006 Jan;43(1):11–23. PubMed PMID: 16412785.Google Scholar

Fraser, CJ, Scott Baker, K. The Management and Outcome of Chronic Graft-versus-Host Disease. British Journal of Haematology. 2007 Jul;138(2):131–45. PubMed PMID: 17593020.Google Scholar

Holler, E. Progress in Acute Graft versus Host Disease. Current Opinion in Hematology. 2007 Nov;14(6):625–31. PubMed PMID: 17898566.Google Scholar

Rodriguez, V, Anderson, PM, Trotz, BA, Arndt, CAS, Allen, JA, Khan, SP. Use of Infliximab-Daclizumab Combination for the Treatment of Acute and Chronic Graft-versus-Host Disease of the Liver and Gut. Pediatric Blood & Cancer. 2007 Aug;49(2):212–5. PubMed PMID: 16261610.Google Scholar

Ferrara, JLM, Reddy, P. Pathophysiology of Graft-versus-Host Disease. Seminars in Hematology. 2006 Jan;43(1):3–10. PubMed PMID: 16412784.Google Scholar

Blazar, BR, Murphy, WJ, Abedi, M. Advances in Graft-versus-Host Disease Biology and Therapy. Nature Reviews Immunology. 2012;12(6):443–58. PubMed PMID: 22576252.CrossRefGoogle ScholarPubMed

Copelan, EA. Hematopoietic Stem-cell Transplantation. New England Journal of Medicine. 2006 Apr 27;354(17):1813–26. PubMed PMID: 16641398.Google Scholar

Steinman, RM. Dendritic Cells: Understanding Immunogenicity. European Journal of Immunology. 2007 Nov;37 Suppl 1:S53–60. PubMed PMID: 17972346.CrossRefGoogle ScholarPubMed

Ludajic, K, Balavarca, Y, Bickeboller, H, Rosenmayr, A, Fae, I, Fischer, GF, et al. KIR Genes and KIR Ligands Affect Occurrence of Acute GVHD after Unrelated, 12/12 HLA Matched, Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant. 2009 01/26/online;44(2):97–103.CrossRefGoogle ScholarPubMed

Chien, JW, Zhang, XC, Fan, W, Wang, H, Zhao, LP, Martin, PJ, et al. Evaluation of Published Single Nucleotide Polymorphisms Associated with Acute GVHD. Blood. 2012;119(22):5311–9. PubMed PMID: 22282500. PubMed Central PMCID: PMC3369619.CrossRefGoogle ScholarPubMed

Schwartz, RH. Historical Overview of Immunological Tolerance. Cold Spring Harbor Perspectives in Biology. 2012;4(4):a006908. PubMed PMID: 22395097.CrossRefGoogle ScholarPubMed

Szabolcs, P, Burlingham, WJ, Thomson, AW. Tolerance after Solid Organ and Hematopoietic Cell Transplantation. Biology of Blood & Marrow Transplantation. 2012;18(1 Suppl):S193–200. PubMed PMID: 22226107. PubMed Central PMCID: NIHMS379899 PMC3374726.Google Scholar

Levitsky, J. Operational Tolerance: Past Lessons and Future Prospects. Liver Transplantation. 2011;17(3):222–32.Google Scholar

Bluestone, JA, Auchincloss, H, Nepom, GT, Rotrosen, D, St. Clair, EW, Turka, LA. The Immune Tolerance Network at 10 Years: Tolerance Research at the Bedside. Nat Rev Immunol. 2010 11//print;10(11):797–803.Google Scholar

Sykes, M. Immune Tolerance: Mechanisms and Application in Clinical Transplantation. Journal of Internal Medicine. 2007 Sep;262(3):288–310. PubMed PMID: 17697153.Google Scholar

Starzl, TE. Chimerism and Tolerance in Transplantation. Proceedings of the National Academy of Sciences of the United States of America. 2004;101 Suppl 2:14607–14. PubMed PMID: 15319473. PubMed Central PMCID: PMC521985.Google Scholar

Perales, MA, Blachere, NE, Engelhorn, ME, Ferrone, CR, Gold, JS, Gregor, PD, et al. Strategies to Overcome Immune Ignorance and Tolerance. Seminars in Cancer Biology. 2002;12(1):63–71. PubMed PMID: 11926414.Google Scholar

Macian, F, Im, S-H, Garcia-Cozar, FJ, Rao, A. T-cell Anergy. Current Opinion in Immunology. 2004 Apr;16(2):209–16. PubMed PMID: 15023415.CrossRefGoogle ScholarPubMed

Brennan, PJ, Saouaf, SJ, Greene, MI, Shen, Y. Anergy and Suppression as Coexistent Mechanisms for the Maintenance of Peripheral T Cell Tolerance. Immunologic Research. 2003;27(2–3):295–302. PubMed PMID: 12857976.CrossRefGoogle ScholarPubMed

Wood, KJ, Bushell, A, Hester, J. Regulatory Immune Cells in Transplantation. Nat Rev Immunol. 2012 06//print;12(6):417–30.Google Scholar

Shuiping, J. Recent Advances in Regulatory T Cells. Seminars in Immunology. 2011;23(6):399–400.Google Scholar

Franck, E, Bonneau, C, Jean, L, Henry, J-P, Lacoume, Y, Salvetti, A, et al. Immunological Tolerance to Muscle Autoantigens Involves Peripheral Deletion of Autoreactive CD8⁺ T Cells. PLoS ONE. 2012;7(5):e36444.Google Scholar

Gurung, P, Kucaba, TA, Schoenberger, SP, Ferguson, TA, Griffith, TS. TRAIL-expressing CD8+ T Cells Mediate Tolerance Following Soluble Peptide-induced Peripheral T Cell Deletion. Journal of Leukocyte Biology. 2010;88(6):1217–25. PubMed PMID: 20807702. PubMed Central PMCID: PMC2996898.CrossRefGoogle ScholarPubMed

Cohen, JN, Guidi, CJ, Tewalt, EF, Qiao, H, Rouhani, SJ, Ruddell, A, et al. Lymph Node–Resident Lymphatic Endothelial Cells Mediate Peripheral Tolerance via Aire-independent Direct Antigen Presentation. The Journal of Experimental Medicine. 2010 April 12, 2010;207(4):681–8.Google Scholar

Gallegos, AM, Bevan, MJ. Central Tolerance: Good but Imperfect. Immunological Reviews. 2006 Feb;209:290–6. PubMed PMID: 16448550.Google Scholar

Kyewski, B, Klein, L. A Central Role for Central Tolerance. Annu Rev Immunol. 2006;24:571–606. PubMed PMID: 16551260.Google Scholar

Mathis, D, Benoist, C. Back to Central Tolerance. Immunity. 2004 May;20(5):509–16. PubMed PMID: 15142520.Google Scholar

Ruiz, P, Streilein, JW. Evidence that I-E-negative Mice Resistant to Neonatal H-2 Tolerance Induction Display Ubiquitous Thymic Clonal Deletion of Donor-reactive T Cells. Transplantation. 1993 Feb;55(2):321–8. PubMed PMID: 8434383. Epub 1993/02/01. English.Google Scholar

Lakkis, FG, Arakelov, A, Konieczny, BT, Inoue, Y. Immunologic ‘Ignorance’ of Vascularized Organ Transplants in the Absence of Secondary Lymphoid Tissue. Nature Medicine. 2000 Jun;6(6):686–8. PubMed PMID: 10835686.Google Scholar

Alegre, M-L, Florquin, S, Goldman, M. Cellular Mechanisms Underlying Acute Graft Rejection: Time for Reassessment. Current Opinion in Immunology. 2007 Oct;19(5):563–8. PubMed PMID: 17720467.Google Scholar

Trambley, J, Bingaman, AW, Lin, A, Elwood, ET, Waitze, SY, Ha, J, et al. Asialo GM1+ CD8+ T Cells Play a Critical Role in Costimulation Blockade-resistant Allograft Rejection. Journal of Clinical Investigation. 1999;104(12):1715–22.Google Scholar

Neujahr, DC, Chen, C, Huang, X, Markmann, JF, Cobbold, S, Waldmann, H, et al. Accelerated Memory Cell Homeostasis during T Cell Depletion and Approaches to Overcome It. Journal of Immunology. 2006;176(8):4632–9.Google Scholar

Gershon, RK. A Disquisition on Suppressor T Cells. Transplantation Reviews. 1975;26:170–85. PubMed PMID: 1101469.Google Scholar

Gershon, RK, Cohen, P, Hencin, R, Liebhaber, SA. Suppressor T Cells. Journal of Immunology. 1972 Mar;108(3):586–90. PubMed PMID: 4401006.Google Scholar

Takahashi, T, Kuniyasu, Y, Toda, M, Sakaguchi, N, Itoh, M, Iwata, M, et al. Immunologic Self-tolerance Maintained by CD25+CD4+ Naturally Anergic and Suppressive T Cells: Induction of Autoimmune Disease by Breaking Their Anergic/Suppressive State. Int Immunol. 1998 December 1, 1998;10(12):1969–80.Google Scholar

Sakaguchi, S, Sakaguchi, N, Asano, M, Itoh, M, Toda, M. Immunologic Self-tolerance Maintained by Activated T Cells Expressing IL-2 Receptor Alpha-chains (CD25). Breakdown of a Single Mechanism of Self-tolerance Causes Various Autoimmune Diseases. Journal of Immunology. 1995 Aug 1;155(3):1151–64. PubMed PMID: 7636184.Google Scholar

Josefowicz, SZ, Lu, LF, Rudensky, AY. Regulatory T Cells: Mechanisms of Differentiation and Function. Annu Rev Immunol. 2012;30:531–64. PubMed PMID: 22224781. Epub 2012/01/10. English.CrossRefGoogle ScholarPubMed

Tang, Q, Bluestone, JA. The Foxp3+ Regulatory T Cell: A Jack of all Trades, Master of Regulation. Nat Immunol. 2008;9(3):239–44.Google Scholar

Bandukwala, HS, Rao, A. ‘Nurr’ishing Treg Cells: Nr4a Transcription Factors Control Foxp3 Expression. Nat Immunol. 2013 03//print;14(3):201–3.Google Scholar

Pot, C, Apetoh, L, Kuchroo, VK. Type 1 Regulatory T Cells (Tr1) in Autoimmunity. Semin Immunol. 2011 Jun;23(3):202–8. PubMed PMID: 21840222. PubMed Central PMCID: PMC3178065. Epub 2011/08/16. English.Google Scholar

Burlingham, WJ, Goulmy, E. Human CD8+ T-regulatory Cells with Low-avidity T-cell Receptor Specific for Minor Histocompatibility Antigens. Hum Immunol. 2008 Nov;69(11):728–31. PubMed PMID: 18812197. PubMed Central PMCID: PMC2665292. Epub 2008/09/25. English.Google Scholar

Monteiro, M, Almeida, CF, Caridade, M, Ribot, JC, Duarte, J, Agua-Doce, A, et al. Identification of Regulatory Foxp3+ Invariant NKT Cells Induced by TGF-beta. J Immunol. 2010 Aug 15;185(4):2157–63. PubMed PMID: 20639482. Epub 2010/07/20. English.Google Scholar

Fischer, K, Voelkl, S, Heymann, J, Przybylski, GK, Mondal, K, Laumer, M, et al. Isolation and Characterization of Human Antigen-specific TCRαβ+ CD4-CD8- Double-negative Regulatory T Cells. Blood. 2005 April 1, 2005;105(7):2828–35.Google Scholar

DiLillo, DJ, Matsushita, T, Tedder, TF. B10 Cells and Regulatory B Cells Balance Immune Responses during Inflammation, Autoimmunity, and Cancer. Ann N Y Acad Sci. 2010;1183(1):38–57.Google Scholar

Morelli, AE, Thomson, AW. Tolerogenic Dendritic Cells and the Quest for Transplant Tolerance. Nat Rev Immunol. 2007 08//print;7(8):610–21.Google Scholar

Haile, LA, von Wasielewski, R, Gamrekelashvili, J, Kruger, C, Bachmann, O, Westendorf, AM, et al. Myeloid-derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway. Gastroenterology. 2008 Sep;135(3):871–81, 81 e1–5. PubMed PMID: 18674538. Epub 2008/08/05. English.Google Scholar

Fleming, BD, Mosser, DM. Regulatory Macrophages: Setting the Threshold for Therapy. Eur J Immunol. 2011 Sep;41(9):2498–502. PubMed PMID: 21952805. Epub 2011/09/29. English.Google Scholar

English, K, French, A, Wood, KJ. Mesenchymal Stromal Cells: Facilitators of Successful Transplantation? Cell Stem Cell. 2010 Oct 8;7(4):431–42. PubMed PMID: 20887949. Epub 2010/10/05. English.Google Scholar

Kim, HJ, Hwang, SJ, Kim, BK, Jung, KC, Chung, DH. NKT Cells Play Critical Roles in the Induction of Oral Tolerance by Inducing Regulatory T Cells Producing IL-10 and Transforming Growth Factor Beta, and by Clonally Deleting Antigen-specific T Cells. Immunology. 2006 May;118(1):101–11. PubMed PMID: 16630027.Google Scholar

Carrier, Y, Yuan, J, Kuchroo, VK, Weiner, HL. Th3 Cells in Peripheral Tolerance. I. Induction of Foxp3-positive Regulatory T Cells by Th3 Cells Derived from TGF-beta T Cell-transgenic Mice. Journal of Immunology. 2007 Jan 1;178(1):179–85. PubMed PMID: 17182553.Google Scholar

Biagi, E, Di Biaso, I, Leoni, V, Gaipa, G, Rossi, V, Bugarin, C, et al. Extracorporeal Photochemotherapy Is Accompanied by Increasing Levels of Circulating CD4+CD25+GITR+Foxp3+CD62 L+ Functional Regulatory T-cells in Patients with Graft-versus-Host Disease. Transplantation. 2007 Jul 15;84(1):31–9. PubMed PMID: 17627234.Google Scholar

Hilchey, SP, De, A, Rimsza, LM, Bankert, RB, Bernstein, SH. Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-costimulated Autologous and Allogeneic CD8+CD25- and CD4+CD25- T Cells. Journal of Immunology. 2007 Apr 1;178(7):4051–61. PubMed PMID: 17371959.Google Scholar

Ferretti, G, Felici, A, Pino, MS, Cognetti, F. Does CTLA4 Influence the Suppressive Effect of CD25+CD4+ Regulatory T Cells? Journal of Clinical Oncology. 2006 Dec 1;24(34):5469–70; author reply 70–1. PubMed PMID: 17135653.Google Scholar

Quezada, SA, Peggs, KS, Curran, MA, Allison, JP. CTLA4 Blockade and GM-CSF Combination Immunotherapy Alters the Intratumor Balance of Effector and Regulatory T Cells. Journal of Clinical Investigation. 2006 Jul;116(7):1935–45. PubMed PMID: 16778987.Google Scholar

Salama, AD, Najafian, N, Clarkson, MR, Harmon, WE, Sayegh, MH. Regulatory CD25+ T Cells in Human Kidney Transplant Recipients. Journal of the American Society of Nephrology. 2003 Jun;14(6):1643–51. PubMed PMID: 12761267.Google Scholar

Cirocco, RE, Carreno, MR, Mathew, JM, Garcia-Morales, RO, Fuller, L, Esquenazi, V, et al. FoxP3 mRNA Transcripts and Regulatory Cells in Renal Transplant Recipients 10 Years after Donor Marrow Infusion. Transplantation. 2007 Jun 27;83(12):1611–9. PubMed PMID: 17589345.Google Scholar

Dijke, IE, Weimar, W, Baan, CC. Regulatory T Cells after Organ Transplantation: Where Does Their Action Take Place? Human Immunology. 2008;69(7):389–98.Google Scholar

Brunstein, CG, Miller, JS, Cao, Q, McKenna, DH, Hippen, KL, Curtsinger, J, et al. Infusion of Ex Vivo Expanded T Regulatory Cells in Adults Transplanted with Umbilical Cord Blood: Safety Profile and Detection Kinetics. Blood. 2010 October 15.Google Scholar

Farkas, SA, Schnitzbauer, AA, Kirchner, G, Obed, A, Banas, B, Schlitt, HJ. Calcineurin Inhibitor Minimization Protocols in Liver Transplantation. Transplant International. Official Journal of the European Society for Organ Transplantation. 2009 Jan;22(1):49–60. PubMed PMID: 19121146. Epub 2009/01/06. English.Google Scholar

Moreira-Teixeira, L, Resende, M, Devergne, O, Herbeuval, J-P, Hermine, O, Schneider, E, et al. Rapamycin Combined with TGF-β Converts Human Invariant NKT Cells into Suppressive Foxp3+ Regulatory Cells. The Journal of Immunology. 2012 January 15, 2012;188(2):624–31.Google Scholar

Ciancio, G, Burke, GW. Alemtuzumab (Campath-1 H) in Kidney Transplantation. American Journal of Transplantation. Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2008 Jan;8(1):15–20. PubMed PMID: 18093269. Epub 2007/12/21. English.Google Scholar

Chiffoleau, E, Walsh, PT, Turka, L. Apoptosis and Transplantation Tolerance. Immunological Reviews. 2003 Jun;193:124–45. PubMed PMID: 12752677.Google Scholar

Sohn, SJ, Thompson, J, Winoto, A. Apoptosis during Negative Selection of Autoreactive Thymocytes. Current Opinion in Immunology. 2007 Oct;19(5):510–5. PubMed PMID: 17656079.Google Scholar

Dresske, B, Lin, X, Huang, D-S, Zhou, X, Fandrich, F. Spontaneous Tolerance: Experience with the Rat Liver Transplant Model. Human Immunology. 2002 Oct;63(10):853–61. PubMed PMID: 12368037.Google Scholar

Vincenti, F, Luggen, M, Vincenti, F, Luggen, M. T cell Costimulation: A Rational Target in the Therapeutic Armamentarium for Autoimmune Diseases and Transplantation. Annual Review of Medicine. 2007;58:347–58. PubMed PMID: 17020493.Google Scholar

Vincenti, F, Larsen, C, Durrbach, A, Wekerle, T, Nashan, B, Blancho, G, et al. Costimulation Blockade with Belatacept in Renal Transplantation. The New England Journal of Medicine. 2005 Aug 25;353(8):770–81. PubMed PMID: 16120857. Epub 2005/08/27. English.Google Scholar

Bonfoco, E, Stuart, PM, Brunner, T, Lin, T, Griffith, TS, Gao, Y, et al. Inducible Nonlymphoid Expression of Fas Ligand Is Responsible for Superantigen-induced Peripheral Deletion of T Cells. Immunity. 1998 Nov;9(5):711–20. PubMed PMID: 9846492.Google Scholar

Kurts, C, Heath, WR, Kosaka, H, Miller, JF, Carbone, FR. The Peripheral Deletion of Autoreactive CD8+ T Cells Induced by Cross-presentation of Self-antigens Involves Signaling through CD95 (Fas, Apo-1). Journal of Experimental Medicine. 1998 Jul 20;188(2):415–20. PubMed PMID: 9670055.Google Scholar

Dempsey, PW, Doyle, SE, He, JQ, Cheng, G. The Signaling Adaptors and Pathways Activated by TNF Superfamily. Cytokine & Growth Factor Reviews. 2003 Jun–Aug;14(3–4):193–209. PubMed PMID: 12787559.Google Scholar

Feng, X. Regulatory Roles and Molecular Signaling of TNF Family Members in Osteoclasts. Gene. 2005 Apr 25;350(1):1–13. PubMed PMID: 15777737.Google Scholar

Sheikh, MS, Huang, Y. Death Receptor Activation Complexes: It Takes Two to Activate TNF Receptor 1. Cell Cycle. 2003 Nov–Dec;2(6):550–2. PubMed PMID: 14504472.Google Scholar

Tryphonopoulos, P, Tzakis, AG, Weppler, D, Garcia-Morales, R, Kato, T, Madariaga, JR, et al. The Role of Donor Bone Marrow Infusions in Withdrawal of Immunosuppression in Adult Liver Allotransplantation. American Journal of Transplantation. 2005 Mar;5(3):608–13. PubMed PMID: 15707417.Google Scholar

Leventhal, J, Abecassis, M, Miller, J, Gallon, L, Ravindra, K, Tollerud, DJ, et al. Chimerism and Tolerance without GVHD or Engraftment Syndrome in HLA-mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation. Science Translational Medicine. 2012 March 7, 2012;4(124):124ra28.Google Scholar

Martinez-Llordella, M, Puig-Pey, I, Orlando, G, Ramoni, M, Tisone, G, Rimola, A, et al. Multiparameter Immune Profiling of Operational Tolerance in Liver Transplantation. American Journal of Transplantation. 2007 Feb;7(2):309–19. PubMed PMID: ISI:000243440100008. eng.Google Scholar

Bohne, F, Martínez-Llordella, M, Lozano, J-J, Miquel, R, Benítez, C, Londoño, M-C, et al. Intra-graft Expression of Genes Involved in Iron Homeostasis Predicts the Development of Operational Tolerance in Human Liver Transplantation. The Journal of Clinical Investigation. 2012;122(1):368–82.Google Scholar

Newell, KA, Asare, A, Kirk, AD, Gisler, TD, Bourcier, K, Suthanthiran, M, et al. Identification of a B Cell Signature Associated with Renal Transplant Tolerance in Humans. The Journal of Clinical Investigation. 2010;120(6):1836–47.Google Scholar

Newell, KA, Larsen, CP. Tolerance Assays: Measuring the Unknown. Transplantation. 2006 Jun 15;81(11):1503–9. PubMed PMID: 16770237.Google Scholar

Londono, MC, Danger, R, Giral, M, Soulillou, JP, Sanchez-Fueyo, A, Brouard, S. A Need for Biomarkers of Operational Tolerance in Liver and Kidney Transplantation. Am J Transplant. 2012 Jun;12(6):1370–7. PubMed PMID: 22486792. Epub 2012/04/11. English.Google Scholar

Nankivell, BJ, Chapman, JR. Chronic Allograft Nephropathy: Current Concepts and Future Directions. Transplantation. 2006 Mar 15;81(5):643–54. PubMed PMID: 16534463.CrossRefGoogle ScholarPubMed

Wood, KJ, Goto, R. Mechanisms of Rejection: Current Perspectives. Transplantation. 2012;93(1):1–10.1097/TP.0b013e31823cab44.Google Scholar

Huang, Y, Rabb, H, Womer, KL. Ischemia-reperfusion and Immediate T Cell Responses. Cellular Immunology. 2007 Jul;248(1):4–11. PubMed PMID: 17942086.Google Scholar

Kupiec-Weglinski, JW, Busuttil, RW. Ischemia and Reperfusion Injury in Liver Transplantation. Transplantation Proceedings. 2005 May;37(4):1653–6. PubMed PMID: 15919422.Google Scholar

Ysebaert, DK, De Greef, KE, De Beuf, A, Van Rompay, AR, Vercauteren, S, Persy, VP, et al. T cells as Mediators in Renal Ischemia/Reperfusion Injury. Kidney International. 2004 Aug;66(2):491–6. PubMed PMID: 15253695.Google Scholar

Andersen, CB, Ladefoged, SD, Larsen, S. Acute Kidney Graft Rejection. A Morphological and Immunohistological Study on “Zero-hour” and Follow-up Biopsies with Special Emphasis on Cellular Infiltrates and Adhesion Molecules. APMIS. 1994;102(1):23–37.Google Scholar

Devouassoux, G, Pison, C, Drouet, C, Pin, I, Brambilla, C, Brambilla, E. Early Lung Leukocyte Infiltration, HLA and Adhesion Molecule Expression Predict Chronic Rejection. Transplant Immunology. 2001 Feb;8(4):229–36. PubMed PMID: 11316065.Google Scholar

van der Woude, FJ, Deckers, JG, Mallat, MJ, Yard, BA, Schrama, E, van Saase, JL, et al. Tissue Antigens in Tubulointerstitial and Vascular Rejection. Kidney International – Supplement. 1995 Dec;52:S11–3. PubMed PMID: 8587271.Google Scholar

Hengstenberg, C, Hufnagel, G, Haverich, A, Olsen, EGJ, Maisch, B. De Novo Expression of MHC Class I and Class II Antigens on Endomyocardial Biopsies from Patients with Inflammatory Heart Disease and Rejection Following Heart Transplantation. European Heart Journal. 1993 January 2;14(6):758–63.Google Scholar

Farr, AG, Mannschreck, JW, Anderson, SK. Expression of Class II MHC Antigens in Murine Pancreas after Streptozocin-induced Insulitis. Diabetes. 1988 October 1;37(10):1373–9.Google Scholar

Hasegawa, S, Becker, G, Nagano, H, Libby, P, Mitchell, RN. Pattern of Graft- and Host-specific MHC Class II Expression in Long-term Murine Cardiac Allografts: Origin of Inflammatory and Vascular Wall Cells. American Journal of Pathology. 1998 Jul;153(1):69–79. PubMed PMID: 9665467.Google Scholar

Haverty, TP, Watanabe, M, Neilson, EG, Kelly, CJ. Protective Modulation of Class II MHC Gene Expression in Tubular Epithelium by Target Antigen-specific Antibodies. Cell-surface Directed Down-regulation of Transcription Can Influence Susceptibility to Murine Tubulointerstitial Nephritis. J Immunol. 1989 August 15;143(4):1133–41.Google Scholar

Adoumie, R, Serrick, C, Giaid, A, Shennib, H, Adoumie, R, Serrick, C, et al. Early Cellular Events in the Lung Allograft. Annals of Thoracic Surgery. 1992 Dec;54(6):1071–6; discussion 6–7. PubMed PMID: 1449289.Google Scholar

Denton, MD, Davis, SF, Baum, MA, Melter, M, Reinders, ME, Exeni, A, et al. The Role of the Graft Endothelium in Transplant Rejection: Evidence that Endothelial Activation May Serve as a Clinical Marker for the Development of Chronic Rejection. Pediatric Transplantation. 2000 Nov;4(4):252–60. PubMed PMID: 11079263.Google Scholar

Baldwin, WM, Larsen, CP, Fairchild, RL. Innate Immune Responses to Transplants: A Significant Variable with Cadaver Donors. Immunity. 2001;14(4):369–76.Google Scholar

Borges, TJ, Wieten, L, van Herwijnen, MJ, Broere, F, van der Zee, R, Bonorino, C, et al. The anti-inflammatory Mechanisms of Hsp70. Front Immunol. 2012;3:95. PubMed PMID: 22566973. PubMed Central PMCID: PMC3343630. Epub 2012/05/09. English.Google Scholar

Jiang, W, Hu, M, Rao, J, Xu, X, Wang, X, Kong, L. Over-expression of Toll-like Receptors and Their Ligands in Small-for-Size Graft. Hepatology Research: The Official Journal of the Japan Society of Hepatology. 2010 Apr;40(4):318–29. PubMed PMID: 20070394. Epub 2010/01/15. English.Google Scholar

Pockley, AG, Muthana, M. Heat Shock Proteins and Allograft Rejection. Contrib Nephrol. 2005;148:122–34. PubMed PMID: 15912031. Epub 2005/05/25. English.Google Scholar

Hiratsuka, M, Yano, M, Mora, BN, Nagahiro, I, Cooper, JD, Patterson, GA, et al. Heat Shock Pretreatment Protects Pulmonary Isografts from Subsequent Ischemia-Reperfusion Injury. Journal of Heart & Lung Transplantation. 1998 Dec;17(12):1238–46. PubMed PMID: 9883766.Google Scholar

Squiers, EC, Bruch, D, Buelow, R, Tice, DG, Squiers, EC, Bruch, D, et al. Pretreatment of Small Bowel Isograft Donors with Cobalt-Protoporphyrin Decreases Preservation Injury. Transplantation Proceedings. 1999 Feb–Mar;31(1–2):585–6. PubMed PMID: 10083247.Google Scholar

Bernink, JH, Peters, CP, Munneke, M, te Velde, AA, Meijer, SL, Weijer, K, et al. Human Type 1 Innate Lymphoid Cells Accumulate in Inflamed Mucosal Tissues. Nat Immunol. 2013 03//print;14(3):221–9.Google Scholar

Ito, T, Connett, JM, Kunkel, SL, Matsukawa, A. The Linkage of Innate and Adaptive Immune Response during Granulomatous Development. Frontiers in Immunology. 2013 January 31;4. eng.Google Scholar

Penfield, JG, Wang, Y, Li, S, Kielar, MA, Sicher, SC, Jeyarajah, DR, et al. Transplant Surgery Injury Recruits Recipient MHC Class II-positive Leukocytes into the Kidney. Kidney International. 1999 Nov;56(5):1759–69. PubMed PMID: 10571784.Google Scholar

Olszewski, WL, Olszewski, WL. Innate Immunity Processes in Organ Allografting–Their Contribution to Acute and Chronic Rejection. Ann Transplant. 2005;10(2):5–9. PubMed PMID: 16218025.Google Scholar

Akalin, E, Watschinger, B. Antibody-mediated Rejection. Seminars in Nephrology. 2007 Jul;27(4):393–407. PubMed PMID: 17616272.Google Scholar

Truong, LD, Barrios, R, Adrogue, HE, Gaber, LW. Acute Antibody-mediated Rejection of Renal Transplant: Pathogenetic and Diagnostic Considerations. Archives of Pathology & Laboratory Medicine. 2007 Aug;131(8):1200–8. PubMed PMID: 17683182.Google Scholar

Horie, K, Kanou, Y, Sato, M, Tsuyuki, M, Ishida, S, Shimoji, T, et al. A Case of Early Graft Loss Due to Hyperacute Rejection after ABO-incompatible Renal Transplantation. Clinical Transplantation. 2008 //;22(s19):42–6.Google Scholar

Baldwin, WM. Samaniego-Picota, M, Kasper, EK, Clark, AM, Czader, M, Rohde, C, et al. Complement Deposition in Early Cardiac Transplant Biopsies Is Associated with Ischemic Injury and Subsequent Rejection Episodes. Transplantation. 1999 Sep 27;68(6):894–900. PubMed PMID: 10515392.Google Scholar

Shimizu, A, Colvin, RB. Pathological Features of Antibody-mediated Rejection. Current Drug Targets – Cardiovascular & Haematological Disorders. 2005 Jun;5(3):199–214. PubMed PMID: 15975034.Google Scholar

Akalin, E, Watschinger, B, Akalin, E, Watschinger, B. Antibody-mediated Rejection. Seminars in Nephrology. 2007 Jul;27(4):393–407. PubMed PMID: 17616272.Google Scholar

Naemi, FM, Ali, S, Kirby, JA. Antibody-mediated Allograft Rejection: The Emerging Role of Endothelial Cell Signalling and Transcription Factors. Transpl Immunol. 2011 Sep;25(2–3):96–103. PubMed PMID: 21782944. Epub 2011/07/26. English.Google Scholar

Zhang, X, Rozengurt, E, Reed, EF. HLA Class I Molecules Partner with Integrin Beta4 to Stimulate Endothelial Cell Proliferation and Migration. Science Signaling. 2010;3(149):ra85. PubMed PMID: 21098729. Epub 2010/11/26. English.Google Scholar

Feucht, HE, Felber, E, Gokel, MJ, Hillebrand, G, Nattermann, U, Brockmeyer, C, et al. Vascular Deposition of Complement-split Products in Kidney Allografts with Cell-mediated Rejection. Clinical & Experimental Immunology. 1991 Dec;86(3):464–70. PubMed PMID: 1747954.Google Scholar

Feucht, HE, Schneeberger, H, Hillebrand, G, Burkhardt, K, Weiss, M, Riethmuller, G, et al. Capillary Deposition of C4d Complement Fragment and Early Renal Graft Loss. Kidney International. 1993;43(6):1333–8.Google Scholar

Banasik, M, Boratynska, M, Nowakowska, B, Halon, A, Koscielska-Kasprzak, K, Drulis-Fajdasz, D, et al. C4D Deposition and Positive Posttransplant Crossmatch Are Not Necessarily Markers of Antibody-mediated Rejection in Renal Allograft Recipients. Transplantation Proceedings. 2007 Nov;39(9):2718–20. PubMed PMID: 18021967.Google Scholar

Seemayer, CA, Gaspert, A, Nickeleit, V, Mihatsch, MJ. C4d Staining of Renal Allograft Biopsies: A Comparative Analysis of Different Staining Techniques. Nephrology Dialysis Transplantation. 2007 Feb;22(2):568–76. PubMed PMID: 17164320.Google Scholar

Sun, Q, Liu, ZH, Ji, S, Chen, J, Tang, Z, Zeng, C, et al. Late and Early C4d-positive Acute Rejection: Different Clinico-histopathological Subentities in Renal Transplantation. Kidney International. 2006 Jul;70(2):377–83. PubMed PMID: 16760909.Google Scholar

Roufosse, CA, Shore, I, Moss, J, Moran, LB, Willicombe, M, Galliford, J, et al. Peritubular Capillary Basement Membrane Multilayering on Electron Microscopy: A Useful Marker of Early Chronic Antibody-mediated Damage. Transplantation. 2012 Aug 15;94(3):269–74. PubMed PMID: 22790448. Epub 2012/07/14. English.Google Scholar

Sis, B, Halloran, PF. Endothelial Transcripts Uncover a Previously Unknown Phenotype: C4d-negative Antibody-mediated Rejection. Curr Opin Organ Transplant. 2010 Feb;15(1):42–8. PubMed PMID: 20009933. Epub 2009/12/17. English.Google Scholar

Mengel, M, Sis, B, Haas, M, Colvin, RB, Halloran, PF, Racusen, LC, et al. BANFF 2011 Meeting Report: New Concepts in Antibody-mediated Rejection. American Journal of Transplantation. 2012;12(3):563–70.Google Scholar

Hammond, ME, Stehlik, J, Snow, G, Renlund, DG, Seaman, J, Dabbas, B, et al. Utility of Histologic Parameters in Screening for Antibody-mediated Rejection of the Cardiac Allograft: A Study of 3,170 Biopsies. J Heart Lung Transplant. 2005 Dec;24(12):2015–21. PubMed PMID: 16364843.Google Scholar

Nankivell, BJ, Alexander, SI. Rejection of the Kidney Allograft. New England Journal of Medicine. 2010;363(15):1451–62. PubMed PMID: 20925547.Google Scholar

Jukes, J-P, Wood, KJ, Jones, ND. Natural Killer T Cells: A Bridge to Tolerance or a Pathway to Rejection? Transplantation. 2007 Sep 27;84(6):679–81. PubMed PMID: 17893598.Google Scholar

Kitchens, WH, Uehara, S, Chase, CM, Colvin, RB, Russell, PS, Madsen, JC. The Changing Role of Natural Killer Cells in Solid Organ Rejection and Tolerance. Transplantation. 2006 Mar 27;81(6):811–7. PubMed PMID: 16570001.Google Scholar

Goldman, M, Le Moine, A, Braun, M, Flamand, V, Abramowicz, D. A Role for Eosinophils in Transplant Rejection. Trends Immunol. 2001 May;22(5):247–51. PubMed PMID: 11323281. Epub 2001/04/27. English.Google Scholar

Chantranuwat, C, Qiao, JH, Kobashigawa, J, Hong, L, Shintaku, P, Fishbein, MC. Immunoperoxidase Staining for C4d on Paraffin-embedded Tissue in Cardiac Allograft Endomyocardial Biopsies: Comparison to Frozen Tissue Immunofluorescence. Appl Immunohistochem Mol Morphol. 2004 Jun;12(2):166–71. PubMed PMID: 15354744.Google Scholar

Aguilar, P, Mathieu, CP, Clerc, G, Ethevenot, G, Fajraoui, M, Mattei, S, et al. Modulation of Natural Killer (NK) Receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) Cells after Heart Transplantation. Journal of Heart & Lung Transplantation. 2006 Feb;25(2):200–5. PubMed PMID: 16446221.Google Scholar

McNerney, ME, Lee, KM, Zhou, P, Molinero, L, Mashayekhi, M, Guzior, D, et al. Role of Natural Killer Cell Subsets in Cardiac Allograft Rejection. American Journal of Transplantation. 2006 Mar;6(3):505–13. PubMed PMID: 16468959.Google Scholar

Sanfilippo, F, Kolbeck, PC, Vaughn, WK, Bollinger, RR. Renal Allograft Cell Infiltrates Associated with Irreversible Rejection. Transplantation. 1985 Dec;40(6):679–85. PubMed PMID: 3907043.Google Scholar

Azzawi, M, Hasleton, PS, Geraghty, PJ, Yonan, N, Krysiak, P, El-Gammal, A, et al. RANTES Chemokine Expression Is Related to Acute Cardiac Cellular Rejection and Infiltration by CD45RO T-lymphocytes and Macrophages. Journal of Heart & Lung Transplantation. 1998 Sep;17(9):881–7. PubMed PMID: 9773860.Google Scholar

Erren, M, Arlt, M, Willeke, P, Schluter, B, Junker, R, Deng, MC, et al. Predictive Value of the CD45RO Positive T-helper Lymphocyte Subset for Acute Cellular Rejection during the Early Phase after Kidney Transplantation. Transplantation Proceedings. 1999 Feb–Mar;31(1–2):319–21. PubMed PMID: 10083125.Google Scholar

Wang, P, Zhu, L, Liu, T, Zhang, X, Qiu, Y. Intragraft CD45 RO Gene Expression Is an Early Marker to Detect Small Bowel Allograft Rejection in Rats. Microsurgery. 1999;19(7):348–50. PubMed PMID: 10586202.Google Scholar

Mueller, TF, Einecke, G, Reeve, J, Sis, B, Mengel, M, Jhangri, GS, et al. Microarray Analysis of Rejection in Human Kidney Transplants using Pathogenesis-based Transcript Sets. Am J Transplant. 2007 Dec;7(12):2712–22. PubMed PMID: 17941957. Epub 2007/10/19. English.Google Scholar

Sarwal, M, Chua, MS, Kambham, N, Hsieh, SC, Satterwhite, T, Masek, M, et al. Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling. The New England Journal of Medicine. 2003 Jul 10;349(2):125–38. PubMed PMID: 12853585. Epub 2003/07/11. English.Google Scholar

Hadley, G. Role of Integrin CD103 in Promoting Destruction of Renal Allografts by CD8 T Cells. American Journal of Transplantation. 2004 Jul;4(7):1026–32. PubMed PMID: 15196058.Google Scholar

Wang, D, Yuan, R, Feng, Y, El-Asady, R, Farber, DL, Gress, RE, et al. Regulation of CD103 Expression by CD8+ T Cells Responding to Renal Allografts. Journal of Immunology. 2004 Jan 1;172(1):214–21. PubMed PMID: 14688328.Google Scholar

Al-Hamidi, A, Pekalski, M, Robertson, H, Ali, S, Kirby, JA. Renal Allograft Rejection: The Contribution of Chemokines to the Adhesion and Retention of AlphaE(CD103)Beta7 Integrin-expressing Intratubular T Cells. Mol Immunol. 2008 Sep;45(15):4000–7. PubMed PMID: 18649941. Epub 2008/07/25. English.Google Scholar

Adams, DH, Afford, SC. Effector Mechanisms of Nonsuppurative Destructive Cholangitis in Graft-versus-Host Disease and Allograft Rejection. Seminars in Liver Disease. 2005 Aug;25(3):281–97. PubMed PMID: 16143944. Epub 2005/09/07. English.Google Scholar

Delacruz, V, Garcia, M, Mittal, N, Nishida, S, Levi, D, Selvaggi, G, et al. Immunoenzymatic and Morphological Detection of Epithelial Cell Apoptotic Stages in Gastrointestinal Allografts from Multivisceral Transplant Patients. Transplantation Proceedings. 2004 Mar;36(2):338–9. PubMed PMID: 15050151.Google Scholar

Alegre, M, Fallarino, F, Zhou, P, Frauwirth, K, Thistlethwaite, J, Newell, K, et al. Transplantation and the CD28/CTLA4/B7 Pathway. Transplantation Proceedings. 2001 Feb–Mar;33(1–2):209–11. PubMed PMID: 11266782.Google Scholar

Clarkson, MR, Sayegh, MH, Clarkson, MR, Sayegh, MH. T-cell Costimulatory Pathways in Allograft Rejection and Tolerance. Transplantation. 2005 Sep 15;80(5):555–63. PubMed PMID: 16177624.Google Scholar

Kitchens, WH, Haridas, D, Wagener, ME, Song, M, Ford, ML. Combined Costimulatory and Leukocyte Functional Antigen-1 Blockade Prevents Transplant Rejection Mediated by Heterologous Immune Memory Alloresponses. Transplantation. 2012 May 27;93(10):997–1005. PubMed PMID: 22475765. Epub 2012/04/06. English.Google Scholar

Ho, J, Wiebe, C, Gibson, IW, Rush, DN, Nickerson, PW. Immune Monitoring of Kidney Allografts. Am J Kidney Dis. 2012 Oct;60(4):629–40. PubMed PMID: 22542291. Epub 2012/05/01. English.Google Scholar

Hodge, G, Hodge, S, Li-Liew, C, Reynolds, PN, Holmes, M. Increased Natural Killer T-like Cells Are a Major Source of Pro-inflammatory Cytokines and Granzymes in Lung Transplant Recipients. Respirology. 2012 Jan;17(1):155–63. PubMed PMID: 21995313. Epub 2011/10/15. English.Google Scholar

Clement, MV, Haddad, P, Soulie, A, Benvenuti, C, Lichtenheld, MG, Podack, ER, et al. Perforin and Granzyme B as Markers for Acute Rejection in Heart Transplantation. International Immunology. 1991 Nov;3(11):1175–81. PubMed PMID: 1760412.Google Scholar

Griffiths, GM, Namikawa, R, Mueller, C, Liu, CC, Young, JD, Billingham, M, et al. Granzyme A and Perforin as Markers for Rejection in Cardiac Transplantation. European Journal of Immunology. 1991 Mar;21(3):687–93. PubMed PMID: 2009911.Google Scholar

Madsen, CB, Norgaard, A, Iversen, M, Ryder, LP. Elevated mRNA Levels of CTLA-4, FoxP3, and Granzyme B in BAL, but Not in Blood, during Acute Rejection of Lung Allografts. Transpl Immunol. 2010 Oct;24(1):26–32. PubMed PMID: 20633650. Epub 2010/07/17. English.Google Scholar

Ahmed-Ansari, A, Tadros, TS, Knopf, WD, Murphy, DA, Hertzler, G, Feighan, J, et al. Major Histocompatibility Complex Class I and Class II Expression by Myocytes in Cardiac Biopsies Posttransplantation. Transplantation. 1988 May;45(5):972–8. PubMed PMID: 3285544.Google Scholar

Barrett, M, Milton, AD, Barrett, J, Taube, D, Bewick, M, Parsons, VP, et al. Needle Biopsy Evaluation of Class II Major Histocompatibility Complex Antigen Expression for the Differential Diagnosis of Cyclosporine Nephrotoxicity from Kidney Graft Rejection. Transplantation. 1987 Aug;44(2):223–7. PubMed PMID: 3307046.Google Scholar

Belitsky, P, Miller, SM, Gupta, R, Lee, S, Ghose, T. Induction of MHC Class II Expression in Recipient Tissues Caused by Allograft Rejection. Transplantation. 1990 Feb;49(2):472–6. PubMed PMID: 2305472.Google Scholar

Briscoe, DM, Cotran, RS. Role of Leukocyte-endothelial Cell Adhesion Molecules in Renal Inflammation: In Vitro and in Vivo Studies. Kidney International – Supplement. 1993 Jul;42:S27–34. PubMed PMID: 8361125.Google Scholar

Heemann, UW, Tullius, SG, Azuma, H, Kupiec-Weglinsky, J, Tilney, NL. Adhesion Molecules and Transplantation. Annals of Surgery. 1994 Jan;219(1):4–12. PubMed PMID: 8297174.Google Scholar

Kirby, JA. The Role Played by Adhesion Molecules during Allograft Rejection. Transplant Immunology. 1994 Jun;2(2):129–32. PubMed PMID: 7953308.Google Scholar

Mulligan, MS, McDuffie, JE, Shanley, TP, Guo, RF, Vidya Sarma, J, Warner, RL, et al. Role of RANTES in Experimental Cardiac Allograft Rejection. Experimental & Molecular Pathology. 2000 Dec;69(3):167–74. PubMed PMID: 11115358.Google Scholar

Schroppel, B, Fischereder, M, Lin, M, Marder, B, Schiano, T, Kramer, BK, et al. Analysis of Gene Polymorphisms in the Regulatory Region of MCP-1, RANTES, and CCR5 in Liver Transplant Recipients. Journal of Clinical Immunology. 2002 Nov;22(6):381–5. PubMed PMID: 12462338.Google Scholar

Miura, M, Morita, K, Kobayashi, H, Hamilton, TA, Burdick, MD, Strieter, RM, et al. Monokine Induced by IFN-gamma Is a Dominant Factor Directing T Cells into Murine Cardiac Allografts during Acute Rejection. Journal of Immunology. 2001 Sep 15;167(6):3494–504. PubMed PMID: 11544343.Google Scholar

Schnickel, GT, Bastani, S, Hsieh, GR, Shefizadeh, A, Bhatia, R, Fishbein, MC, et al. Combined CXCR3/CCR5 Blockade Attenuates Acute and Chronic Rejection. J Immunol. 2008 April 1, 2008;180(7):4714–21.Google Scholar

Merani, S, Truong, WW, Hancock, W, Anderson, CC, Shapiro, AMJ. Chemokines and Their Receptors in Islet Allograft Rejection and as Targets for Tolerance Induction. Cell Transplantation. 2006;15(4):295–309. PubMed PMID: 16898223.CrossRefGoogle ScholarPubMed

Smith, RN, Ueno, T, Ito, T, Tanaka, K, Shea, SP, Abdi, R. Chemokines and Chronic Heart Allograft Rejection. Transplantation. 2007 Aug 15;84(3):442–4. PubMed PMID: 17700176.Google Scholar

Stasikowska, O, Wagrowska-Danilewicz, M. Chemokines and Chemokine Receptors in Glomerulonephritis and Renal Allograft Rejection. Medical Science Monitor. 2007 Feb;13(2):RA31–6. PubMed PMID: 17261994.Google Scholar

Smith, RN, Colvin, RB. Chronic Alloantibody Mediated Rejection. Semin Immunol. 2012 Apr;24(2):115–21. PubMed PMID: 22051115. Epub 2011/11/05. English.Google Scholar

Takeda, A, Horike, K, Ohtsuka, Y, Inaguma, D, Goto, N, Watarai, Y, et al. Current Problems of Chronic Active Antibody-mediated Rejection. Clin Transplant. 2011 Jul;25 Suppl 23:2–5. PubMed PMID: 21623906. Epub 2011/06/03. English.Google Scholar

Arias, M, Seron, D, Moreso, F, Bestard, O, Praga, M. Chronic Renal Allograft Damage: Existing Challenges. Transplantation. 2011 May 15;91(9 Suppl):S4–25. PubMed PMID: 21519213. Epub 2011/04/29. English.Google Scholar

Hayry, P. Chronic Allograft Vasculopathy: New Strategies for Drug Development. Transplantation proceedings. 1998 Dec;30(8):3989–90. PubMed PMID: 9865271.Google Scholar

Lachmann, N, Terasaki, PI, Schonemann, C, Lachmann, N, Terasaki, PI, Schonemann, C. Donor-specific HLA Antibodies in Chronic Renal Allograft Rejection: A Prospective Trial with a Four-year Follow-up. Clinical Transplants. 2006:171–99. PubMed PMID: 18365377.Google Scholar

Takahashi, H, Kato, T, Mizutani, K, Terasaki, P, Delacruz, V, Tzakis, AG, et al. Simultaneous Antibody-mediated Rejection of Multiple Allografts in Modified Multivisceral Transplantation. Clinical Transplants. 2006:529–34. PubMed PMID: 18365419.Google Scholar

Terasaki, P, Lachmann, N, Cai, J. Summary of the Effect of de Novo HLA Antibodies on Chronic Kidney Graft Failure. Clinical Transplants. 2006:455–62. PubMed PMID: 18365403.Google Scholar

Denton, MD, Davis, SF, Baum, MA, Melter, M, Reinders, ME, Exeni, A, et al. The Role of the Graft Endothelium in Transplant Rejection: Evidence that Endothelial Activation May Serve as a Clinical Marker for the Development of Chronic Rejection. Pediatric Transplantation. 2000 Nov;4(4):252–60. PubMed PMID: 11079263.Google Scholar

Kauppinen, H, Soots, A, Krogerus, L, Brummer, T, Ahonen, J, Lautenschlager, I. Different Expression of Adhesion Molecules ICAM-1 and VCAM-1 and Activation Markers MHC Class II and IL-2 R in Acute and Chronic Rejection of Rat Kidney Allografts. Transplantation Proceedings. 1997 Nov;29(7):3150–1. PubMed PMID: 9365703.Google Scholar

Grimm, PC, Nickerson, P, Jeffery, J, Savani, RC, Gough, J, McKenna, RM, et al. Neointimal and Tubulointerstitial Infiltration by Recipient Mesenchymal Cells in Chronic Renal-allograft Rejection. The New England Journal of Medicine. 2001 July 12;345(2):93–7.Google Scholar

Allan, JS, Madsen, JC. Recent Advances in the Immunology of Chronic Rejection. Current Opinion in Nephrology & Hypertension. 2002 May;11(3):315–21. PubMed PMID: 11981262.Google Scholar

Ozdemir, BH, Ozdemir, FN, Gungen, Y, Haberal, M. Role of Macrophages and Lymphocytes in the Induction of Neovascularization in Renal Allograft Rejection. American Journal of Kidney Diseases. 2002 Feb;39(2):347–53. PubMed PMID: 11840376.Google Scholar

Ravalli, S, Albala, A, Ming, M, Szabolcs, M, Barbone, A, Michler, RE, et al. Inducible Nitric Oxide Synthase Expression in Smooth Muscle Cells and Macrophages of Human Transplant Coronary Artery Disease. Circulation. 1998 Jun 16;97(23):2338–45. PubMed PMID: 9639378.Google Scholar

de Andrade, JA, Thannickal, VJ. Innovative Approaches to the Therapy of Fibrosis. Curr Opin Rheumatol. 2009 Nov;21(6):649–55. PubMed PMID: 19667993. Pubmed Central PMCID: PMC2862988. Epub 2009/08/12. English.Google Scholar

Wynn, TA. Cellular and Molecular Mechanisms of Fibrosis. Journal of Pathology. 2008 Jan;214(2):199–210. PubMed PMID: 18161745.Google Scholar

Nadeau, KC, Azuma, H, Tilney, NL. Sequential Cytokine Dynamics in Chronic Rejection of Rat Renal Allografts: Roles for Cytokines RANTES and MCP-1. Proceedings of the National Academy of Sciences of the United States of America. 1995 Sep 12;92(19):8729–33. PubMed PMID: 7568006.Google Scholar

Russell, ME, Wallace, AF, Hancock, WW, Sayegh, MH, Adams, DH, Sibinga, NE, et al. Upregulation of Cytokines Associated with Macrophage Activation in the Lewis-to-F344 Rat Transplantation Model of Chronic Cardiac Rejection. Transplantation. 1995 Feb 27;59(4):572–8. PubMed PMID: 7533347.Google Scholar

Csencsits, K, Wood, SC, Lu, G, Faust, SM, Brigstock, D, Eichwald, EJ, et al. Transforming Growth Factor Beta-induced Connective Tissue Growth Factor and Chronic Allograft Rejection. American Journal of Transplantation. 2006 May;6(5 Pt 1):959–66. PubMed PMID: 16611331.Google Scholar

Rintala, JM, Savikko, J, Rintala, SE, von Willebrand, E. The Effect of Leflunomide Analogue FK778 on Development of Chronic Rat Renal Allograft Rejection and Transforming Growth Factor-BETA Expression. Transplantation Proceedings. 2006 Dec;38(10):3239–40. PubMed PMID: 17175234.Google Scholar

Barocci, S, Ginevri, F, Valente, U, Torre, F, Gusmano, R, Nocera, A. Correlation between Angiotensin-converting Enzyme Gene Insertion/Deletion Polymorphism and Kidney Graft Long-term Outcome in Pediatric Recipients: A Single-center Analysis. Transplantation. 1999 Feb 27;67(4):534–8. PubMed PMID: 10071023.Google Scholar

Ikegami, M, Nagano, T, Hara, Y, Negita, M, Imanishi, M, Ishii, T, et al. [Tissue Type Plasminogen Activator (t-PA) and Plasminogen Activator Inhibitor (PAI) in Transplanted Kidneys]. Nippon Hinyokika Gakkai Zasshi – Japanese Journal of Urology. 1995 May;86(5):991–5. PubMed PMID: 7596085.Google Scholar

Legendre, C, Pascual, M. Improving Outcomes for Solid-organ Transplant Recipients at Risk from Cytomegalovirus Infection: Late-onset Disease and Indirect Consequences. Clinical Infectious Diseases. 2008 Mar 1;46(5):732–40. PubMed PMID: 18220478.Google Scholar

Grossi, PA, Costa, AN, Fehily, D, Blumberg, EA, Kuehnert, MJ, Fishman, JA, et al. Infections and Organ Transplantation: New Challenges for Prevention and Treatment—A Colloquium. Transplantation. 2012;93:S4–S39 10.1097/TP.0b013e3182481347.Google Scholar

Egli, A, Binggeli, S, Bodaghi, S, Dumoulin, A, Funk, GA, Khanna, N, et al. Cytomegalovirus and Polyomavirus BK Posttransplant. Nephrology Dialysis Transplantation. 2007 Sep;22 Suppl 8:viii72–viii82. PubMed PMID: 17890268.Google Scholar

Steininger, C. Clinical Relevance of Cytomegalovirus Infection in Patients with Disorders of the Immune System. Clinical Microbiology & Infection. 2007 Oct;13(10):953–63. PubMed PMID: 17803749.Google Scholar

Watkins, RR, Lemonovich, TL, Razonable, RR. Immune Response to CMV in Solid Organ Transplant Recipients: Current Concepts and Future Directions. Expert Review of Clinical Immunology. 2012 May;8(4):383–93. PubMed PMID: 22607184. Epub 2012/05/23. English.Google Scholar

Streblow, DN, Orloff, SL, Nelson, JA. Acceleration of Allograft Failure by Cytomegalovirus. Current Opinion in Immunology. 2007 Oct;19(5):577–82. PubMed PMID: 17716883.Google Scholar

Potena, L, Valantine, HA. Cytomegalovirus-associated Allograft Rejection in Heart Transplant Patients. Current Opinion in Infectious Diseases. 2007 Aug;20(4):425–31. PubMed PMID: 17609604.Google Scholar

Valantine, H. Cardiac Allograft Vasculopathy after Heart Transplantation: Risk Factors and Management. J Heart Lung Transplant. 2004 May;23(5 Suppl):S187–93. PubMed PMID: 15093804.Google Scholar

Carratala, J, Montejo, M, Perez-Romero, P. Infections Caused by Herpes Viruses Other than Cytomegalovirus in Solid Organ Transplant Recipients. Enferm Infecc Microbiol Clin. 2012 Mar;30 Suppl 2:63–9. PubMed PMID: 22542037. Epub 2012/05/11. English.Google Scholar

Bennett, SM, Broekema, NM, Imperiale, MJ. BK Polyomavirus: Emerging Pathogen. Microbes and infection / Institut Pasteur. 2012 Aug;14(9):672–83. PubMed PMID: 22402031. PubMed Central PMCID: PMC3568954. Epub 2012/03/10. English.Google Scholar

Acott, P, Babel, N. BK Virus Replication Following Kidney Transplant: Does the Choice of Immunosuppressive Regimen Influence Outcomes? Ann Transplant. 2012 Jan–Mar;17(1):86–99. PubMed PMID: 22466913. Epub 2012/04/03. English.Google Scholar

Delbue, S, Ferraresso, M, Ghio, L, Carloni, C, Carluccio, S, Belingheri, M, et al. A Review on JC Virus Infection in Kidney Transplant Recipients. Clinical & Developmental Immunology. 2013;2013:926391. PubMed PMID: 23424601. PubMed Central PMCID: PMC3569895. Epub 2013/02/21. English.Google Scholar

Hirsch, HH, Drachenberg, CB, Steiger, J, Ramos, E. Polyomavirus Associated Nephropathy in Renal Transplantation: Critical Issues of Screening and Management. In: Ahsan, N, editor. Polyomaviruses and Human Diseases. Advances in Experimental Medicine and Biology, vol. 577. 1st ed. New York, N.Y. Georgetown, T.X.: Springer Science+Business Media, Landes Bioscience / Eurekah.com; 2006. p. 160–73.Google Scholar

Nishi, S. Polyomavirus Nephropathy – Recent Pathological Diagnostic Problems and the Report from the 2011 BANFF Meeting. Clin Transplant. 2012 Jul;26 Suppl 24:9–12. PubMed PMID: 22747469. Epub 2012/07/07. English.Google Scholar

Duvoux, C, Firpi, R, Grazi, GL, Levy, G, Renner, E, Villamil, F. Recurrent Hepatitis C Virus Infection Post Liver Transplantation: Impact of Choice of Calcineurin Inhibitor. Transpl Int. 2013 Feb 18. PubMed PMID: 23413991. Epub 2013/02/19. English.Google Scholar

Manzia, TM, Angelico, R, Toti, L, Lai, Q, Ciano, P, Angelico, M, et al. Hepatitis C Virus Recurrence and Immunosuppression-free State after Liver Transplantation. Expert Review of Clinical Immunology. 2012 Sep;8(7):635–44. PubMed PMID: 23078061. Epub 2012/10/20. English.Google Scholar

Dixon, LR, Crawford, JM. Early Histologic Changes in Fibrosing Cholestatic Hepatitis C. Liver Transpl. 2007 Feb;13(2):219–26. PubMed PMID: 17205558.Google Scholar

Neff, GW, Shire, N, Ruiz, P, O’Brien, C, Garcia, M, Dela Garza, J, et al. The Importance of Clinical Parameters when Differentiating Cholestatic Hepatitis C Virus from Allograft Rejection. Transplantation Proceedings. 2005 Dec;37(10):4397–402. PubMed PMID: 16387130.Google Scholar

Ge, D, Fellay, J, Thompson, AJ, Simon, JS, Shianna, KV, Urban, TJ, et al. Genetic Variation in IL28B Predicts Hepatitis C Treatment-induced Viral Clearance. Nature. 2009;461(7262):399–401.Google Scholar

Nayak, NC, Sachdeva, R. Localization of Hepatitis B Surface Antigen in Conventional Paraffin Sections of the Liver. Comparison of Immunofluorescence, Immunoperoxidase, and Orcein Staining Methods with Regard to Their Specificity and Reliability as Antigen Marker. American Journal of Pathology 1975 81(3):479–92.Google Scholar

Green, M, Michaels, MG. Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder. Am J Transplant. 2013 Feb;13 Suppl 3:41–54; quiz PubMed PMID: 23347213. Epub 2013/02/01. English.Google Scholar

Morscio, J, Dierickx, D, Ferreiro, JF, Herreman, A, Van Loo, P, Bittoun, E, et al. Gene Expression Profiling Reveals Clear Differences between EBV-positive and EBV-negative Posttransplant Lymphoproliferative Disorders. Am J Transplant. 2013 Mar 14. PubMed PMID: 23489474. Epub 2013/03/16. English.Google Scholar

Kennedy, C, Obilana, A, O’Brien, F, O’Kelly, P, Dorman, A, Denton, M, et al. Glomerular Disease Recurrence in Second and Subsequent Kidney Transplants. Clin Nephrol. 2013 Jan;79(1):31–6. PubMed PMID: 23073068. Epub 2012/10/18. English.Google Scholar

Moroni, G, Casati, C, Quaglini, S, Gallelli, B, Banfi, G, Montagnino, G, et al. Membranoproliferative Glomerulonephritis Type I in Renal Transplantation Patients: A Single-center Study of a Cohort of 68 Renal Transplants Followed up for 11 Years. Transplantation. 2011 Jun 15;91(11):1233–9. PubMed PMID: 21502910. Epub 2011/04/20. English.Google Scholar

Pham, PT, Pham, PC. Graft Loss Due to Recurrent Lupus Nephritis in Living-related Kidney Donation. Clin J Am Soc Nephrol. 2011 Sep;6(9):2296–9. PubMed PMID: 21799149. Pubmed Central PMCID: PMC3359005. Epub 2011/07/30. English.Google Scholar